Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tela Bio Inc. (TELA:NASDAQ), powered by AI.
Tela Bio Inc. is currently trading at $0.90. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Tela Bio Inc. on Alpha Lenz.
View Tela Bio Inc.'s valuation metrics on Alpha Lenz.
“Tela Bio Inc.'s ROE is -223.4%. Explore profitability and growth together.”
Ask for details →Tela Bio Inc. is a company specialized in the development and commercialization of innovative soft tissue reconstruction solutions. The company's primary focus is on providing advanced medical products designed to improve the performance of soft tissue repair options, particularly in the fields of general surgery and hernia repair. Tela Bio Inc.'s portfolio includes its proprietary OviTex and OviTex PRS product lines, which incorporate biologic and synthetic materials to offer better performance and clinical outcomes compared to traditional materials. In the healthcare sector, Tela Bio operates at the intersection of biotechnology and medical devices, addressing the critical needs of surgeons and patients for more efficient and reliable surgical repairs. Tela Bio's innovative solutions are contributing to enhanced patient care, offering reduced complications and better integration with the body’s natural tissue. Headquartered in the United States, the company plays a significant role in the medical field by pushing the boundaries of soft tissue reconstruction technologies, which are vital for enhancing surgical techniques and outcomes.
“Tela Bio Inc.'s ROE is -223.4%. Explore profitability and growth together.”
Ask for details →Tela Bio Inc. (ticker: TELA) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 209 employees.
The current price is $0.897 with a P/E ratio of -x and P/B of -x.
ROE is -223.35% and operating margin is -42.05%. Annual revenue is $80M.